{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:38Z","timestamp":1759333538032,"version":"build-2065373602"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jaad.2007.07.051","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T07:53:39Z","timestamp":1203062019000},"page":"361-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["New viral vaccines for dermatologic disease"],"prefix":"10.1016","volume":"58","author":[{"given":"Christine Orlova","family":"Urman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.07.051_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: Human papillomavirus and cervical cancer\u2014burden and assessment of causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jaad.2007.07.051_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2007.07.051_bib4","first-page":"S326","article-title":"Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases","volume":"24S3","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2007.07.051_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","article-title":"Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia","volume":"31","author":"Schiffman","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jaad.2007.07.051_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0738-081X(97)00008-4","article-title":"Human papillomaviruses: general features","volume":"15","author":"Favre","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2007.07.051_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00130404-200309000-00005","article-title":"The virology of cervical neoplasia: an HPV-associated malignancy","volume":"9","author":"Stoler","year":"2003","journal-title":"Cancer J"},{"key":"10.1016\/j.jaad.2007.07.051_bib8","first-page":"415","article-title":"Molecular virology and epidemiology of human papillomavirus and cervical cancer","volume":"4","author":"Palefsky","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2007.07.051_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cncr.21664","article-title":"Distribution of human papillomavirus types in ThinPrep Papanicolau tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes","volume":"106","author":"Evans","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2007.07.051_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2007.07.051_bib11","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24S3","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2007.07.051_bib12","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2007.07.051_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(02)07368-3","article-title":"HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study","volume":"359","author":"Conley","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.07.051_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007435-199301000-00003","article-title":"Physical and psychological effects of anogenital warts on female patients","volume":"20","author":"Persson","year":"1993","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib15","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib16","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00007435-199904001-00002","article-title":"Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel","volume":"26","author":"Cates","year":"1999","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/rmv.416","article-title":"Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer","volume":"14","author":"Bekkers","year":"2004","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jaad.2007.07.051_bib18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(86)90483-6","article-title":"Human papillomavirus genomes in penile smears of healthy men","volume":"2","author":"Grussendorf-Conen","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.07.051_bib19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jnci\/83.14.997","article-title":"Determinants of genital human papillomavirus infection in young women","volume":"83","author":"Ley","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2007.07.051_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00007435-199607000-00013","article-title":"Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors","volume":"23","author":"Burk","year":"1996","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007435-200009000-00003","article-title":"van der Brule AJ. Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity","volume":"27","author":"Kjaer","year":"2000","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/00016349609047103","article-title":"Symptomatic genital papillomavirus infection in a community. Incidence and clinical picture","volume":"75","author":"Persson","year":"1996","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jaad.2007.07.051_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00001622-200309000-00007","article-title":"Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy","volume":"15","author":"Palefsky","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jaad.2007.07.051_bib24","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","article-title":"Cancer burden in the year 2000. The global picture","volume":"37","author":"Parkin","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2007.07.051_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2007.07.051_bib26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jnci\/djg040","article-title":"Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control","volume":"95","author":"Weir","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2007.07.051_bib27","unstructured":"Overview: Cervical cancer: How many women get cancer of the cervix? American Cancer Socety, Inc. Available at: http:\/\/www.cancer.org\/docroot\/CRI\/content\/CRI_2_2_1X_How_many_women_get_cancer_of_the_cervix_8.asp?sitearea=. Accessed July 2, 2006."},{"key":"10.1016\/j.jaad.2007.07.051_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2007.07.051_bib29","first-page":"337","article-title":"Direct medical costs for surgical and medical treatment of condylomata acuminata","volume":"137","author":"Alam","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.07.051_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaad.2007.07.051_bib31","first-page":"101","article-title":"High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse)","volume":"10","author":"Kjaer","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2007.07.051_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/10454411000110020801","article-title":"Human papillomavirus infections in children: the potential role of maternal transmission","volume":"11","author":"Syrjanen","year":"2000","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00130404-200309000-00004","article-title":"The epidemiology of cervical cancer","volume":"9","author":"Franco","year":"2003","journal-title":"Cancer J"},{"key":"10.1016\/j.jaad.2007.07.051_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0966-842X(94)90627-0","article-title":"Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses","volume":"2","author":"Pater","year":"1994","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jaad.2007.07.051_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/infdis\/172.2.395","article-title":"Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups","volume":"172","author":"Heim","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrmicro867","article-title":"Delivering on the promise: HPV vaccines and cervical cancer","volume":"2","author":"Schiller","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jaad.2007.07.051_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0738-081X(97)00049-7","article-title":"Cellular immunity in cutaneous and genital HPV infections","volume":"15","author":"Malejczyk","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2007.07.051_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study","volume":"325","author":"Kjaer","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2007.07.051_bib40","first-page":"108","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaad.2007.07.051_bib41","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.vaccine.2006.05.110","article-title":"Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms","volume":"24S3","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2007.07.051_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0190-9622(86)70219-3","article-title":"Langerhans cells in molluscum contagiosum, verruca vulgaris, plantar wart, and condyloma acuminatum","volume":"15","author":"Bhawan","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.07.051_bib43","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.10084","article-title":"Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix","volume":"97","author":"Giannini","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2007.07.051_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.1771","article-title":"E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions","volume":"206","author":"Hubert","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2007.07.051_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2005.02282.x","article-title":"High-risk human papillomavirus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract","volume":"117","author":"Jimenez-Flores","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jaad.2007.07.051_bib46","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.humpath.2004.08.012","article-title":"Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions","volume":"35","author":"Azar","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2007.07.051_bib47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.virol.2005.01.029","article-title":"HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels","volume":"334","author":"Fernandes","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jaad.2007.07.051_bib48","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/JCM.43.8.3932-3937.2005","article-title":"Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil","volume":"43","author":"Sim\u00f5es","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2007.07.051_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF03401564","article-title":"Association between HLA DQB \u2217 03 and cervical intra-epithelial neoplasia","volume":"1","author":"Odunsi","year":"1995","journal-title":"Mol Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/(SICI)1097-0215(19960904)67:5<595::AID-IJC1>3.0.CO;2-P","article-title":"Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles","volume":"67","author":"Odunsi","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2007.07.051_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/30400","article-title":"Role of a p53 polymorphism in the development of\u00a0human papillomavirus-associated cancer","volume":"393","author":"Storey","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2007.07.051_bib52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/beog.2001.0213","article-title":"Human papillomavirus and cervical carcinogenesis","volume":"15","author":"Stanley","year":"2001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jaad.2007.07.051_bib53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.21193","article-title":"The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence","volume":"117","author":"Garcia-Closas","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2007.07.051_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2007.07.051_bib55","unstructured":"Merck's New Cervical Cancer Vaccine, Gardasil\u00ae, Unanimously Recommended by CDC Advisory Panel for Vaccination of Girls and Women 11 to 26 Years. Available at: http:\/\/www.merck.com\/newsroom\/press_releases\/product\/2006_0629.html. Accessed July 4, 2006."},{"key":"10.1016\/j.jaad.2007.07.051_bib56","unstructured":"Merck's Cervical Cancer Vaccine, GARDASIL\u00ae, added to the CDC vaccines for children contract. Available at: http:\/\/www.merck.com\/newsroom\/press_releases\/product\/2006_1101.html. Accessed November 4, 2006."},{"key":"10.1016\/j.jaad.2007.07.051_bib57","unstructured":"European Commission Approves GARDASIL\u00ae, Merck's Cervical Cancer Vaccine. Available at: http:\/\/www.merck.com\/newsroom\/press_releases\/product\/2006_0922a.html. Accessed November 4, 2006."},{"key":"10.1016\/j.jaad.2007.07.051_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","article-title":"Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine","volume":"93","author":"Harro","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2007.07.051_bib59","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2007.07.051_bib60","unstructured":"Gardasil\u00ae Information for Healthcare Professionals. Available at: http:\/\/www.gardasil.com\/hcp.html. Accessed July 15, 2006."},{"key":"10.1016\/j.jaad.2007.07.051_bib61","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.07.051_bib62","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ajcp\/102.6.768","article-title":"Immunological events in regressing genital warts","volume":"102","author":"Coleman","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2007.07.051_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0738-081X(96)00165-4","article-title":"Vaccination against papillomavirus in cattle","volume":"15","author":"Campo","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2007.07.051_bib64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0361-090X(02)00125-3","article-title":"Gene gun-mediated intracutaneous vaccination with papillomavirus E7 gene delays cancer development of papillomavirus-induced skin papillomas on rabbits","volume":"26","author":"Han","year":"2002","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.jaad.2007.07.051_bib65","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1086\/498164","article-title":"Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination","volume":"192","author":"Vandepapeliere","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib66","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1056\/NEJM200205303462219","article-title":"Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer","volume":"346","author":"Santin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib67","first-page":"1075","article-title":"Herpes zoster and postherpetic neuralgia: prevention and management","volume":"72","author":"Mounsey","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2007.07.051_bib68","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2007.07.051_bib69","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","article-title":"Herpes zoster infection after autologous bone marrow transplantation","volume":"74","author":"Schuchter","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.07.051_bib70","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/clinids\/21.2.370","article-title":"Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus","volume":"21","author":"Glesby","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0891-5520(05)70313-5","article-title":"The epidemiology of varicella-zoster virus infections","volume":"10","author":"Wharton","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jaad.2007.07.051_bib73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S095026880400281X","article-title":"Incidence of herpes zoster, 1997-2002","volume":"133","author":"Mullooly","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jaad.2007.07.051_bib74","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.06.012","article-title":"Herpes zoster in immunocompromised patients: incidence, timing, and risk factors","volume":"118","author":"Wung","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib75","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.vaccine.2003.10.042","article-title":"Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology","volume":"23","author":"Goldman","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2007.07.051_bib76","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-5-68","article-title":"The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003","volume":"5","author":"Yih","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jaad.2007.07.051_bib77","first-page":"59","article-title":"Varicella immunization and herpes zoster","volume":"12","author":"Volpi","year":"2005","journal-title":"Herpes"},{"key":"10.1016\/j.jaad.2007.07.051_bib78","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.jaad.2007.07.051_bib79","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.287.17.2211","article-title":"Varicella vaccine and shingles","volume":"287","author":"Brisson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2007.07.051_bib80","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.mi.45.100191.001405","article-title":"Varicella-zoster virus latency","volume":"45","author":"Croen","year":"1991","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jaad.2007.07.051_bib82","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/166.Supplement_1.S13","article-title":"Comparative biology of latent varicella-zoster virus and herpes simplex virus infections","volume":"166","author":"Meier","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib83","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2133.2005.06849.x","article-title":"The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles","volume":"153","author":"Morizane","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.051_bib84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0891-5520(05)70319-6","article-title":"The varicella vaccine. Prevention of herpes zoster","volume":"10","author":"Levin","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jaad.2007.07.051_bib85","first-page":"211","article-title":"Natural history of varicella zoster virus","volume":"11","author":"Tyring","year":"1992","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.jaad.2007.07.051_bib86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/CMR.18.1.70-80.2005","article-title":"Preventing varicella-zoster disease","volume":"18","author":"Hambleton","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2007.07.051_bib87","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib88","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/S0264-410X(99)00552-6","article-title":"Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older","volume":"18","author":"Levine","year":"2000","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2007.07.051_bib89","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/jmv.10318","article-title":"Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization","volume":"70","author":"Smith","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaad.2007.07.051_bib90","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1086\/514264","article-title":"Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect","volume":"178","author":"Levin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.051_bib91","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/vim.1996.9.241","article-title":"Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine","volume":"9","author":"Hayward","year":"1996","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jaad.2007.07.051_bib92","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/vim.1994.7.31","article-title":"Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults","volume":"7","author":"Hayward","year":"1994","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jaad.2007.07.051_bib93","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib94","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.07.051_bib95","unstructured":"Zostavax\u00ae. Available at: http:\/\/www.zostavax.com\/. Accessed July 15, 2006."},{"key":"10.1016\/j.jaad.2007.07.051_bib96","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"Edmunds","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2007.07.051_bib97","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-145-5-200609050-00004","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"145","author":"Hornberger","year":"2006","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220702275X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220702275X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:11:21Z","timestamp":1759270281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220702275X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S019096220702275X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.051","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New viral vaccines for dermatologic disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}